26 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 26 of 26 clinical reviews.
Clinical guide to the dutasteride and estradiol HRT drug interaction. Covers pharmacokinetic and pharmacodynamic mechanisms, VTE risk overlap, severity rating, dose adjustments, and monitoring protocols.
A source-audited look at the dutasteride (Avodart) and acetaminophen interaction, covering metabolic pathways, hepatic safety considerations, and what remains unverified.
A guide to the dutasteride, atorvastatin drug interaction: CYP3A4 mechanism, severity, monitoring parameters, dose considerations, and patient counseling for BPH and statin co-therapy.
A clinician-level review of the dutasteride, bupropion drug interaction, covering CYP enzyme pathways, seizure-threshold considerations, monitoring protocols, and patient counseling points.
A detailed clinical review of the dutasteride-levothyroxine drug interaction, covering absorption mechanisms, severity ratings, monitoring parameters, and patient counseling for safe co-administration.
Can you take dutasteride (Avodart) with omeprazole or pantoprazole? A guide covering CYP3A4 metabolism, absorption effects, severity ratings, and dose-adjustment recommendations.
A detailed clinical review of the dutasteride-prednisone drug interaction, covering pharmacokinetics, mechanism, severity, monitoring parameters, and patient counseling based on FDA labels and primary literature.
A detailed clinical review of the dutasteride, pregabalin drug interaction, covering pharmacokinetic mechanisms, CNS risk, severity classification, monitoring parameters, and patient counseling points backed by primary literature.
What is established, what is plausible but unproven, and what remains unverified about combining dutasteride (Avodart) with oral micronized progesterone HRT: mechanisms, sedation risk, shared metabolic pathway, and monitoring points.
A detailed clinical review of the dutasteride, rivaroxaban drug interaction, covering CYP3A4/P-gp mechanisms, severity classification, monitoring recommendations, and patient counseling points.
A guide to the dutasteride-simvastatin drug interaction: CYP3A4 mechanism, clinical severity, rhabdomyolysis risk, monitoring parameters, and evidence-based dose guidance.
Can you take dutasteride (Avodart) with SNRIs like venlafaxine or duloxetine? Review of CYP3A4 pharmacokinetics, serotonin and blood pressure considerations, monitoring protocols, and dose-adjustment guidance.
A clinician-level review of the dutasteride, SSRI drug interaction, covering CYP450 pharmacokinetics, sexual side-effect overlap, serotonin syndrome risk, and practical prescribing guidance for men on Avodart plus sertraline or escitalopram.
Evidence-based review of the dutasteride and apixaban drug interaction, including CYP3A4/P-gp mechanism, severity rating, monitoring labs, dose adjustments, and patient counseling.
Board-reviewed guide on the dutasteride and benzodiazepines interaction, covering CYP3A4 metabolism overlap, clinical severity, monitoring, and dose-adjustment recommendations.
Is it safe to take dutasteride (Avodart) with clopidogrel (Plavix)? A clinician-level review of CYP metabolism, DDI severity ratings, monitoring guidance, and surgical considerations for BPH patients on antiplatelet therapy.
Can you take dutasteride with hormonal contraceptives? Review the pharmacokinetic and pharmacodynamic interaction profile, clinical risks, CYP3A4 overlap, and monitoring recommendations.
Is it safe to take dutasteride (Avodart) with metformin? A guide covering CYP metabolism, clinical evidence, monitoring protocols, and dose-adjustment considerations.
Can you take Avodart with ibuprofen or naproxen? A guide to the dutasteride-NSAID interaction covering pharmacology, bleeding risk, renal effects, and clinical monitoring.
Can you take Avodart with oxycodone, hydrocodone, or tramadol? A guide to the dutasteride-opioid interaction covering CYP metabolism, severity ratings, dose adjustment, and monitoring.
A source-audited guide to combining dutasteride (Avodart) with testosterone replacement therapy: what is established about the DHT-testosterone pharmacodynamic interaction, what monitoring is reasonable, and where the evidence needs verification.
A clinical review of the dutasteride-trazodone drug interaction covering CYP3A4 metabolism, pharmacodynamic overlap, severity grading, monitoring parameters, and dose-adjustment guidance.
Evidence-based analysis of the dutasteride-warfarin drug interaction, covering CYP metabolism, bleeding risk, INR monitoring protocols, and practical prescribing considerations.
Can you take Avodart (dutasteride) with gabapentin? A guide covering mechanism, severity, monitoring, dose adjustment, and patient counseling for this drug combination.
A pharmacology-based review of taking dutasteride (Avodart) with rosuvastatin (Crestor). Covers CYP3A4 versus OATP/BCRP metabolism, what monitoring is actually needed, and what remains unverified.
Can you take Avodart (dutasteride) with tadalafil? What the pharmacology and BPH combination-therapy evidence actually support, what remains unverified, and where a third drug changes the risk picture.